| Q36598969 | A combined system for engineering glycosylation efficiency and glycan structure in Saccharomyces cerevisiae |
| Q51440619 | A dual approach for improving homogeneity of a human-type N-glycan structure in Saccharomyces cerevisiae. |
| Q36233127 | A perfusion-capable microfluidic bioreactor for assessing microbial heterologous protein production |
| Q92635836 | Alpha-Gal and Cross-Reactive Carbohydrate Determinants in the N-Glycans of Salivary Glands in the Lone Star Tick, Amblyomma americanum |
| Q26823830 | Applications of Yeast Surface Display for Protein Engineering |
| Q89476992 | Applications of Yeast Synthetic Biology Geared towards the Production of Biopharmaceuticals |
| Q37644186 | Applications of recombinant Pichia pastoris in the healthcare industry. |
| Q50870145 | Comparative Study on Different Expression Hosts for Alkaline Phytase Engineered in Escherichia coli. |
| Q51213349 | Development of N- and O-linked oligosaccharide engineered Saccharomyces cerevisiae strain. |
| Q42018981 | Development of a fed-batch process for a recombinant Pichia pastoris Δoch1 strain expressing a plant peroxidase |
| Q35092308 | Directed evolution of a yeast-displayed HIV-1 SOSIP gp140 spike protein toward improved expression and affinity for conformational antibodies |
| Q58601813 | Display of the HIV envelope protein at the yeast cell surface for immunogen development |
| Q34328488 | Engineering Yarrowia lipolytica to produce glycoproteins homogeneously modified with the universal Man3GlcNAc2 N-glycan core |
| Q42380751 | Engineering the yeast Yarrowia lipolytica for the production of therapeutic proteins homogeneously glycosylated with Man₈GlcNAc₂ and Man₅GlcNAc₂. |
| Q90586043 | Engineering two species of yeast as cell factories for 2'-fucosyllactose |
| Q41470415 | Enhancement of the gene targeting efficiency of non-conventional yeasts by increasing genetic redundancy |
| Q51210715 | Expression of a high sweetness and heat-resistant mutant of sweet-tasting protein, monellin, in Pichia pastoris with a constitutive GAPDH promoter and modified N-terminus. |
| Q44535729 | Expression of glycoproteins bearing complex human-like glycans with galactose terminal in Hansenula polymorpha |
| Q96231571 | Functional production of human antibody by the filamentous fungus Aspergillus oryzae |
| Q35001998 | Glycosylation analysis of recombinant neutral protease I from Aspergillus oryzae expressed in Pichia pastoris |
| Q38126913 | Glycosylation: impact, control and improvement during therapeutic protein production. |
| Q41669365 | Heterologous Expression, Purification and Immunoreactivity of the Antigen 5 from Polybia paulista Wasp Venom |
| Q43029450 | Heterologous expression of a thermophilic esterase in Kluyveromyces yeasts |
| Q51809882 | Heterologous production of a feruloyl esterase from Pleurotus sapidus synthesizing feruloyl-saccharide esters. |
| Q35893270 | High-level expression and characterization of a glycosylated human cementum protein 1 with lectin activity. |
| Q34467557 | High-level expression of endo-β-N-acetylglucosaminidase H from Streptomyces plicatus in Pichia pastoris and its application for the deglycosylation of glycoproteins |
| Q41310672 | Identification of novel α1,3-galactosyltransferase and elimination of α-galactose-containing glycans by disruption of multiple α-galactosyltransferase genes in Schizosaccharomyces pombe |
| Q30389345 | Improved production of a recombinant Rhizomucor miehei lipase expressed in Pichia pastoris and its application for conversion of microalgae oil to biodiesel |
| Q41958651 | Knockout of an endogenous mannosyltransferase increases the homogeneity of glycoproteins produced in Pichia pastoris. |
| Q38191909 | Making recombinant proteins in filamentous fungi- are we expecting too much? |
| Q38831292 | Microalgae as Solar-Powered Protein Factories |
| Q37910964 | Microscopic characterisation of filamentous microbes: towards fully automated morphological quantification through image analysis. |
| Q38092339 | New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris. |
| Q35214601 | Overexpression of membrane proteins from higher eukaryotes in yeasts |
| Q90439288 | Overview of Gene Expression Using Filamentous Fungi |
| Q90163464 | Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae |
| Q38078461 | Pichia pastoris: protein production host and model organism for biomedical research |
| Q41999038 | Playing catch-up with Escherichia coli: using yeast to increase success rates in recombinant protein production experiments. |
| Q38012151 | Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation |
| Q38205379 | Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. |
| Q38230560 | Protein folding and secretion: mechanistic insights advancing recombinant protein production in S. cerevisiae. |
| Q38735052 | Rabies vaccine development by expression of recombinant viral glycoprotein |
| Q38306512 | Recombinant protein subunit vaccine synthesis in microbes: a role for yeast? |
| Q39422292 | Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms. |
| Q84006157 | Remodeling of the glycosylation pathway in the methylotrophic yeast Hansenula polymorpha to produce human hybrid-type N-glycans |
| Q46919990 | Systematic assessment of Pichia pastoris system for optimized β -galactosidase production |
| Q34330672 | The biotechnological use and potential of plant pathogenic smut fungi |
| Q45943699 | The recombinant serine protease XAoz1 of Arthrobotrys oligospora exhibits potent nematicidal activity against Caenorhabditis elegans and Haemonchus contortus. |
| Q33761506 | The yin and yang of yeast: biodiversity research and systems biology as complementary forces driving innovation in biotechnology. |